Denmark proposes 6 initiatives to lower drug prices – met with skepticism by industry association
Should pharmacies in Denmark be more competitive, and would this benefit patients in the end? The Danish Competition Council and the Association of the Pharmaceutical Industry, Lif, vehemently disagree.
by ulrich quistgaard, translated by daniel pedersen
The Danish Competition Council has composed six recommendations to sharpen the competition between pharmacies in Denmark with the aim of securing lower drug prices, better service, and perhaps even more new products.
An HR expert points to increasing competition for skilled workers combined with their pandemic fatigue as factors behind initiatives like Novo Nordisk’s advanced salary talks, Genmab’s extra day off a month, and Bavarian Nordic’s gift of four vacation days.